Search Results 351-360 of 849 for NDC
This research is being done to evaluate the safety and tolerability of the new drug, axatilimab, in combination with olaparib (a standard of care treatment) ...
About this study. The primary purpose of this study is to select and validate candidate methylated DNA markers (MDMs) (individually and in combined panels) ...
There is currently no efficacious treatment available for PF-ILD. Based on its efficacy and safety in Idiopatic Pulmonary Fibrosis (IPF), it is anticipated that ...
Heath RR, Nguyen DT, Tzou WS, Sauer WH. Bicuspid ventricular tachycardia in a patient with syncope and a structurally normal heart. Cardiac Electrophysiology ...
Maximizing organ donors. Mayo Clinic researchers are developing innovative preservation methods that make more donated livers usable for transplant, helping to ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
About this study. RATIONALE: Vaccines made from a gene-modified virus may help the body build an effective immune response to kill tumor cells.
To evaluate the efficacy of Cinryze® given for the treatment of acute antibody-mediated rejection (of renal allograft) (AMR) in kidney transplant recipients as ...
Trastuzumab and pertuzumab are monoclonal antibodies and forms of targeted therapy that attach to a receptor protein called HER2. HER2 is found on some cancer ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.